QRS duration is a risk indicator of adverse outcomes after MitraClip

While QRS duration is a known marker of left ventricular (LV) function, little is known about its utility for predicting clinical prognosis after transcatheter mitral valve repair (TMVR). We investigated the association between QRS duration and one‐year adverse events after TMVR with the MitraClip system.

[1]  M. Mack,et al.  Transcatheter Mitral‐Valve Repair in Patients with Heart Failure , 2018, The New England journal of medicine.

[2]  D. Maucort-Boulch,et al.  Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation , 2018, The New England journal of medicine.

[3]  Y. Hayashi,et al.  Mortality impact of post-discharge myocardial infarction size after percutaneous coronary intervention: a patient-level pooled analysis from the 4 large-scale Japanese studies , 2018, Cardiovascular Intervention and Therapeutics.

[4]  K. Tanabe,et al.  The impact of coronary calcification on angiographic and 3-year clinical outcomes of everolimus-eluting stents: results of a XIENCE V/PROMUS post-marketing surveillance study , 2018, Cardiovascular Intervention and Therapeutics.

[5]  O. Alfieri,et al.  Outcome after percutaneous edge-to-edge mitral repair for functional and degenerative mitral regurgitation: a systematic review and meta-analysis , 2017, Heart.

[6]  L. Fleisher,et al.  2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2017, Journal of the American College of Cardiology.

[7]  Jeroen J. Bax,et al.  QRS duration versus morphology and survival after cardiac resynchronization therapy , 2016, ESC heart failure.

[8]  Jeroen J. Bax,et al.  2017 ESC/EACTS Guidelines for the management of valvular heart disease. , 2017, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[9]  E. Frangou,et al.  Large-scale community echocardiographic screening reveals a major burden of undiagnosed valvular heart disease in older people: the OxVALVE Population Cohort Study. , 2016, European heart journal.

[10]  J. Hausleiter,et al.  Impact of Preprocedural Left Ventricular Ejection Fraction on 1-Year Outcomes After MitraClip Implantation (from the ACCESS-EU Phase I, a Prospective, Multicenter, Nonrandomized Postapproval Study of the MitraClip Therapy in Europe). , 2016, The American journal of cardiology.

[11]  Volkmar Falk,et al.  2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure , 2016, Revista espanola de cardiologia.

[12]  Akshay S. Desai,et al.  QRS Duration Is a Predictor of Adverse Outcomes in Heart Failure With Preserved Ejection Fraction. , 2016, JACC. Heart failure.

[13]  M. Guerrero,et al.  MitraClip Therapy for Mitral Regurgitation: Secondary Mitral Regurgitation. , 2016, Interventional cardiology clinics.

[14]  Volkmar Falk,et al.  2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure. , 2016, Revista espanola de cardiologia.

[15]  G. Filippatos,et al.  Clinical Trial Design Principles and Endpoint Definitions for Transcatheter Mitral Valve Repair and Replacement: Part 2: Endpoint Definitions: A Consensus Document From the Mitral Valve Academic Research Consortium. , 2015, Journal of the American College of Cardiology.

[16]  S. Blankenberg,et al.  Percutaneous mitral valve edge-to-edge repair: in-hospital results and 1-year follow-up of 628 patients of the 2011-2012 Pilot European Sentinel Registry. , 2014, Journal of the American College of Cardiology.

[17]  Brandon K. Fornwalt,et al.  QRS duration predicts death and hospitalization among patients with atrial fibrillation irrespective of heart failure: evidence from the AFFIRM study. , 2014, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[18]  P. Pibarot,et al.  Left ventricular systolic function in ischemic mitral regurgitation: time to look beyond ejection fraction. , 2013, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[19]  M. Gold,et al.  Impact of Ejection Fraction on the Clinical Response to Cardiac Resynchronization Therapy in Mild Heart Failure , 2013, Circulation. Heart failure.

[20]  William T. Abraham,et al.  An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality in patients with symptomatic heart failure , 2013, European heart journal.

[21]  Y. Kanda,et al.  Investigation of the freely available easy-to-use software ‘EZR' for medical statistics , 2012, Bone Marrow Transplantation.

[22]  Jennifer Taylor,et al.  ESC/EACTS Guidelines on the management of valvular heart disease. , 2012, European heart journal.

[23]  Andrew J. Boyle,et al.  Cardiomyopathy of aging in the mammalian heart is characterized by myocardial hypertrophy, fibrosis and a predisposition towards cardiomyocyte apoptosis and autophagy , 2011, Experimental Gerontology.

[24]  A. Branzi,et al.  Prognostic implications of functional mitral regurgitation according to the severity of the underlying chronic heart failure: a long‐term outcome study , 2010, European journal of heart failure.

[25]  O. Alfieri,et al.  Long‐term prognosis of medically treated patients with functional mitral regurgitation and left ventricular dysfunction , 2009, European journal of heart failure.

[26]  M. Josephson,et al.  AHA/ACCF/HRS Recommendations for the Standardization and Interpretation of the Electrocardiogram Part VI： Acute Ischemia/Infarction , 2010 .

[27]  E. W. Hancock,et al.  AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part VI: acute ischemia/infarction: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Card , 2009, Journal of the American College of Cardiology.

[28]  D. Gibson,et al.  Natural history of abnormal conduction and its relation to prognosis in patients with dilated cardiomyopathy. , 1996, International journal of cardiology.

[29]  I. Shiraishi,et al.  Quantitative Histological Analysis of the Human Sinoatrial Node During Growth and Aging , 1992, Circulation.

[30]  G. Somes,et al.  On the relationship between heart weights, fibrosis, and QRS duration. , 1975, Journal of electrocardiology.